tiprankstipranks
Avita Medical Ltd (RCEL)
NASDAQ:RCEL
US Market
RCEL
Avita Medical
RESEARCH TOOLSreports
Want to see RCEL full AI Analyst Report?

Avita Medical (RCEL) Ratios

425 Followers

Avita Medical Ratios

RCEL's free cash flow for Q1 2026 was AU$0.82. For the 2026 fiscal year, RCEL's free cash flow was decreased by AU$ and operating cash flow was AU$-0.48. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.47 0.57 2.83 7.88 8.18
Quick Ratio
 0.38 0.46 2.47 7.46 7.98
Cash Ratio
 0.12 0.16 0.70 1.68 1.70
Solvency Ratio
 -0.57 -0.63 -0.81 -0.56 -1.93
Operating Cash Flow Ratio
 -0.46 -0.50 -2.43 -2.88 -1.79
Short-Term Operating Cash Flow Coverage
 -0.67 -0.73 0.00 0.00 0.00
Net Current Asset Value
AU$ -43.06M$ -37.55M$ -18.21M$ 41.42M$ 73.93M
Leverage Ratios
Debt-to-Assets Ratio
 0.93 0.82 0.58 0.38 <0.01
Debt-to-Equity Ratio
 -2.08 -2.77 10.22 0.86 0.01
Debt-to-Capital Ratio
 1.93 1.57 0.91 0.46 0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.90 0.45 0.00
Financial Leverage Ratio
 -2.22 -3.39 17.72 2.28 1.16
Debt Service Coverage Ratio
 -0.73 -0.86 -10.33 -29.40 0.00
Interest Coverage Ratio
 -7.61 -8.50 -10.56 -37.32 0.00
Debt to Market Cap
 0.36 0.45 0.13 0.11 0.00
Interest Debt Per Share
 174.57 1.83 1.98 1.72 0.04
Net Debt to EBITDA
 -1.06 -0.87 -0.58 -0.60 0.66
Profitability Margins
Gross Profit Margin
81.36%82.13%85.85%84.48%82.45%
EBIT Margin
-55.53%-60.85%-87.83%-68.15%-77.32%
EBITDA Margin
-52.14%-57.57%-86.07%-66.89%-75.67%
Operating Profit Margin
-54.61%-59.40%-88.08%-85.07%-79.91%
Pretax Profit Margin
-62.68%-67.83%-96.17%-70.43%-77.36%
Net Profit Margin
-62.67%-67.85%-96.26%-70.56%-77.47%
Continuous Operations Profit Margin
-62.67%-67.85%-96.26%-70.56%-77.47%
Net Income Per EBT
99.98%100.02%100.09%100.19%100.14%
EBT Per EBIT
114.77%114.21%109.18%82.79%96.82%
Return on Assets (ROA)
-87.96%-86.16%-77.59%-31.69%-27.14%
Return on Equity (ROE)
305.45%291.81%-1374.64%-72.12%-31.47%
Return on Capital Employed (ROCE)
261.20%676.75%-95.03%-43.33%-31.41%
Return on Invested Capital (ROIC)
-127.38%-113.04%-93.61%-42.94%-31.19%
Return on Tangible Assets
-98.34%-95.74%-83.42%-31.83%-27.27%
Earnings Yield
-2888.20%-50.55%-18.67%-10.18%-16.16%
Efficiency Ratios
Receivables Turnover
 7.31 7.86 5.37 6.33 6.94
Payables Turnover
 1.87 1.43 1.44 2.05 2.01
Inventory Turnover
 2.20 1.85 1.25 1.39 2.84
Fixed Asset Turnover
 6.65 6.21 4.73 11.62 16.78
Asset Turnover
 1.40 1.27 0.81 0.45 0.35
Working Capital Turnover Ratio
 -2.33 14.83 1.01 0.60 0.43
Cash Conversion Cycle
 20.07 -11.58 107.09 142.25 -0.39
Days of Sales Outstanding
 49.93 46.42 67.96 57.66 52.60
Days of Inventory Outstanding
 165.58 197.59 291.75 262.54 128.39
Days of Payables Outstanding
 195.44 255.59 252.62 177.95 181.38
Operating Cycle
 215.51 244.01 359.71 320.20 180.99
Cash Flow Ratios
Operating Cash Flow Per Share
 -101.37 -1.12 -1.89 -1.50 -0.76
Free Cash Flow Per Share
 -100.67 -1.18 -2.25 -1.56 -0.78
CapEx Per Share
 0.69 0.06 0.36 0.06 0.02
Free Cash Flow to Operating Cash Flow
 0.99 1.06 1.19 1.04 1.03
Dividend Paid and CapEx Coverage Ratio
 -146.03 -17.94 -5.24 -26.27 -36.36
Capital Expenditure Coverage Ratio
 -146.03 -17.94 -5.24 -26.27 -36.36
Operating Cash Flow Coverage Ratio
 -0.64 -0.68 -1.06 -0.90 -20.80
Operating Cash Flow to Sales Ratio
 -0.43 -0.44 -0.76 -0.76 -0.55
Free Cash Flow Yield
-24.08%-34.26%-17.59%-11.35%-11.89%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.14 -1.98 -5.36 -9.82 -6.19
Price-to-Sales (P/S) Ratio
 1.75 1.34 5.16 6.93 4.79
Price-to-Book (P/B) Ratio
 -0.07 -5.77 73.64 7.08 1.95
Price-to-Free Cash Flow (P/FCF) Ratio
 -4.12 -2.92 -5.69 -8.81 -8.41
Price-to-Operating Cash Flow Ratio
 -0.05 -3.08 -6.77 -9.14 -8.64
Price-to-Earnings Growth (PEG) Ratio
 <0.01 0.07 -0.08 0.91 -0.12
Price-to-Fair Value
 -0.07 -5.77 73.64 7.08 1.95
Enterprise Value Multiple
 -4.41 -3.20 -6.57 -10.97 -5.67
Enterprise Value
 167.50M 131.92M 363.24M 367.84M 147.76M
EV to EBITDA
 -4.44 -3.20 -6.57 -10.97 -5.67
EV to Sales
 2.32 1.84 5.65 7.34 4.29
EV to Free Cash Flow
 -5.45 -4.01 -6.23 -9.32 -7.53
EV to Operating Cash Flow
 -5.41 -4.23 -7.42 -9.68 -7.74
Tangible Book Value Per Share
 -93.67 -0.80 -0.04 1.92 3.37
Shareholders’ Equity Per Share
 -75.85 -0.60 0.17 1.94 3.39
Tax and Other Ratios
Effective Tax Rate
 <0.01 >-0.01 >-0.01 >-0.01 >-0.01
Revenue Per Share
 236.89 2.57 2.48 1.98 1.38
Net Income Per Share
 -148.45 -1.74 -2.39 -1.40 -1.07
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 1.13 1.11 1.10 1.03 1.00
Research & Development to Revenue
 0.28 0.29 0.32 0.42 0.40
SG&A to Revenue
 1.08 1.12 1.42 0.57 0.68
Stock-Based Compensation to Revenue
 0.11 0.13 0.21 0.17 0.20
Income Quality
 0.68 0.64 0.79 1.07 0.72